Oligodendroglioma other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
(→Biopsy) |
(→Biopsy) |
||
Line 26: | Line 26: | ||
*Lesions in accessible and relatively “silent” areas of the brain or in areas of the brain with a mild postoperative neurologic deficit | *Lesions in accessible and relatively “silent” areas of the brain or in areas of the brain with a mild postoperative neurologic deficit | ||
*Appearance consistent with [[tumor]] on the [[MRI]] | *Appearance consistent with [[tumor]] on the [[MRI]] | ||
*Large tumors exerting mass effect | *Large [[tumors]] exerting mass effect | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | |
Revision as of 17:13, 12 October 2015
Oligodendroglioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oligodendroglioma other diagnostic studies On the Web |
American Roentgen Ray Society Images of Oligodendroglioma other diagnostic studies |
Risk calculators and risk factors for Oligodendroglioma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Other diagnostic studies for oligodendroglioma include biopsy and fluorescent in-situ hybridization (FISH) technique.
Other Diagnostic Studies
Biopsy
Biopsy demonstrates
- Biopsy may be done at the time of surgical resection of oligodendroglioma.
- Biopsy may be performed to help confirm the diagnosis of oligodendroglioma.
- Biopsy may be of two types: open or stereotactic.
- Indications for open biopsy and stereotactic biopsy are described below:[1]
Type of biopsy | Indications |
---|---|
|
Fluorescent in-situ hybridization (FISH) technique
- FISH demonstrates deletions of chromosome 1p and 19q.[2]
References
- ↑ Eskandar EN, Loeffler JS, O'Neill AM, Hunter GJ, Louis DN (2004). "Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion". N Engl J Med. 351 (18): 1875–82. doi:10.1056/NEJMcpc049025. PMID 15509821.
- ↑ Ersen, Ayca (2008), Pathology of malignant gliomas: Challenges of everyday practice and the WHO 2007, Turkish Journal of Pathology, retrieved 9 October, 2015 Check date values in:
|accessdate=
(help)